{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:12:31Z","timestamp":1788426751793,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ijrobp.2026.03.033","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:58:35Z","timestamp":1774486715000},"page":"405-414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Executive Summary of the American Radium Society Appropriate Use Criteria for Selective Use of Pelvic Radiation Therapy in Locally Advanced Rectal Cancer: A Consensus Statement"],"prefix":"10.1016","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4789-449X","authenticated-orcid":false,"given":"Leila T","family":"Tchelebi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishan R.","family":"Jethwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Dozios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwen","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Abood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitriy","family":"Akselrod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Attallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Chamil","family":"Codipilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Hallemeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Percy","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane C.","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil B.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navesh","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"William","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2026.03.033_bib0001","doi-asserted-by":"crossref","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0002","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0003","series-title":"The RAND\/UCLA Appropriateness Method User\u2019s Manual","author":"Fitch","year":"2001"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0004","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1200\/JCO.2005.08.144","article-title":"Swedish rectal cancer trial: Long lasting benefits from radiotherapy on survival and local recurrence rate","volume":"23","author":"Folkesson","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0005","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.sla.0000257358.56863.ce","article-title":"The TME trial after a median follow-up of 6 years: Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma","volume":"246","author":"Peeters","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0006","article-title":"Upper rectal cancer: To irradiate or not?","volume":"16","author":"Darawsha","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.625459","article-title":"Which definition of upper rectal cancer is optimal in selecting stage II or III rectal cancer patients to avoid postoperative adjuvant radiation?","volume":"10","author":"Gao","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0008","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3393\/ac.2018.09.28","article-title":"Oncologic outcomes of postoperative chemoradiotherapy versus chemotherapy alone in stage II and III upper rectal cancer","volume":"35","author":"Yoon","year":"2019","journal-title":"Ann Coloproctol"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0009","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00423-014-1243-1","article-title":"Adenocarcinomas of the upper third of the rectum and the rectosigmoid junction seem to have similar prognosis as colon cancers even without radiotherapy, SAKK 40\/87","volume":"400","author":"K\u00e4ser","year":"2015","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0010","first-page":"e361","article-title":"Comparative oncologic outcomes of upper third rectal cancers: A meta-analysis","volume":"18","author":"Clancy","year":"2019","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0011","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamaoncol.2019.0186","article-title":"Safety and feasibility of using magnetic resonance imaging criteria to identify patients with \"good prognosis\" rectal cancer eligible for primary surgery: The phase 2 nonrandomized QuickSilver Clinical Trial","volume":"5","author":"Kennedy","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0012","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11605-015-3011-0","article-title":"Use of preoperative magnetic resonance imaging to select patients with rectal cancer for neoadjuvant chemoradiation\u2013interim analysis of the German OCUM Trial (NCT01325649)","volume":"20","author":"Kreis","year":"2016","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0013","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1200\/JCO.22.02166","article-title":"Risk-adapted neoadjuvant chemoradiotherapy in rectal cancer: Final report of the OCUM Study","volume":"41","author":"Ruppert","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0014","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S2468-1253(22)00439-3","article-title":"Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: An open-label, single-centre phase 2 study","volume":"8","author":"Chen","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0015","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1200\/JCO.22.01351","article-title":"Neoadjuvant pembrolizumab in localized microsatellite instability high\/deficient mismatch repair solid tumors","volume":"41","author":"Ludford","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0016","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa2404512","article-title":"Nonoperative management of mismatch repair-deficient tumors","volume":"392","author":"Cercek","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0017","doi-asserted-by":"crossref","first-page":"8697","DOI":"10.1200\/JCO.2005.02.9017","article-title":"Adverse effects of preoperative radiation therapy for rectal cancer: Long-term follow-up of the Swedish Rectal Cancer Trial","volume":"23","author":"Birgisson","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0018","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1245\/s10434-012-2827-z","article-title":"Effect of preoperative radio(chemo)therapy on long-term functional outcome in rectal cancer patients: A systematic review and meta-analysis","volume":"20","author":"Loos","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0019","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1200\/JCO.23.01208","article-title":"Long-term results of organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy: The randomized phase II OPRA trial","volume":"42","author":"Verheij","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0020","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1200\/JCO.22.00184","article-title":"Neoadjuvant chemotherapy, excision, and observation for early rectal cancer: The phase II NEO trial (CCTG CO.28) primary end point results","volume":"41","author":"Kennecke","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0021","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1634\/theoncologist.2014-0233","article-title":"Preoperative chemotherapy in patients with intermediate-risk rectal adenocarcinoma selected by high-resolution magnetic resonance imaging: The GEMCAD 0801 phase II multicenter trial","volume":"19","author":"Fernandez-Martos","year":"2014","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0022","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1093\/annonc\/mdw162","article-title":"A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II\/III rectal cancer (JFMC35-C1: ACTS-RC)","volume":"27","author":"Oki","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0023","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10147-018-1372-6","article-title":"Neoadjuvant CAPOX and bevacizumab alone for locally advanced rectal cancer: Long-term results from the N-SOG 03 trial","volume":"24","author":"Tomida","year":"2019","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0024","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1200\/JCO.2016.66.6198","article-title":"Modified FOLFOX6 with or without radiation versus fluorouracil and leucovorin with radiation in neoadjuvant treatment of locally advanced rectal cancer: Initial results of the Chinese FOWARC multicenter, open-label, randomized three-arm phase III trial","volume":"34","author":"Deng","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0025","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1200\/JCO.18.02309","article-title":"Neoadjuvant modified FOLFOX6 with or without radiation versus fluorouracil plus radiation for locally advanced rectal cancer: Final results of the Chinese FOWARC trial","volume":"37","author":"Deng","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0026","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1200\/JCO-24-01676","article-title":"Neoadjuvant modified infusional fluorouracil, leucovorin, and oxaliplatin with or without radiation versus fluorouracil plus radiation for locally advanced rectal cancer: Updated results of the FOWARC study after a median follow-up of 10 years","volume":"43","author":"Zhang","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0027","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/SLA.0000000000005780","article-title":"Neoadjuvant chemotherapy with CAPOX versus chemoradiation for locally advanced rectal cancer with uninvolved mesorectal fascia (CONVERT): Initial results of a phase III trial","volume":"277","author":"Mei","year":"2023","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0028","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa2303269","article-title":"Preoperative treatment of locally advanced rectal cancer","volume":"389","author":"Schrag","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0029","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1200\/JCO.23.00903","article-title":"Patient-reported outcomes during and after treatment for locally advanced rectal cancer in the PROSPECT trial (alliance N1048)","volume":"41","author":"Basch","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0030","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/DCR.0000000000002153","article-title":"Tailored strategy for locally advanced rectal carcinoma (GRECCAR 4): Long-term results from a multicenter, randomized, open-label, phase II trial","volume":"65","author":"Rouanet","year":"2022","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2018.e00804","article-title":"BACCHUS: A randomised non-comparative phase II study of neoadjuvant chemotherapy (NACT) in patients with locally advanced rectal cancer (LARC)","volume":"4","author":"Glynne-Jones","year":"2018","journal-title":"Heliyon"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0032","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/ags3.12720","article-title":"Neoadjuvant S-1 and oxaliplatin plus bevacizumab therapy for high-risk locally advanced rectal cancer: A prospective multicenter phase II study","volume":"8","author":"Miura","year":"2023","journal-title":"Ann Gastroenterol Surg"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0033","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1200\/JCO.2012.45.3258","article-title":"Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-Year follow-up results of the MERCURY study","volume":"32","author":"Taylor","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0034","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/jjco\/hyac080","article-title":"A randomized controlled trial comparing perioperative vs. postoperative mFOLFOX6 for lower rectal cancer with suspected lateral pelvic lymph node metastasis (JCOG1310): A phase II\/III randomized controlled trial","volume":"52","author":"Ohue","year":"2022","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0035","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ags3.12873","article-title":"Upfront surgery, neoadjuvant chemoradiotherapy, or neoadjuvant chemotherapy for rectal cancer with lateral lymph node metastasis: A multicenter MRI and lateral lymph node dissection study","volume":"9","author":"Miura","year":"2024","journal-title":"Ann Gastroenterol Surg"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0036","doi-asserted-by":"crossref","first-page":"e526","DOI":"10.1097\/SLA.0000000000005755","article-title":"Negative prognostic impact of tumor deposits in rectal cancer: A national study cohort","volume":"278","author":"Agger","year":"2023","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0037","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00384-019-03452-6","article-title":"Neoadjuvant chemoradiation improves oncologic outcomes in low and mid clinical T3N0 rectal cancers","volume":"35","author":"Lavryk","year":"2020","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.ijrobp.2026.03.033_bib0038","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/annonc\/mdu029","article-title":"EMVI-positive stage II rectal cancer has similar clinical outcomes as stage III disease following pre-operative chemoradiotherapy","volume":"25","author":"Chand","year":"2014","journal-title":"Ann Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162600516X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162600516X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:16:03Z","timestamp":1788423363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030162600516X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S036030162600516X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.03.033","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Executive Summary of the American Radium Society Appropriate Use Criteria for Selective Use of Pelvic Radiation Therapy in Locally Advanced Rectal Cancer: A Consensus Statement","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.03.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}